Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases

2009 ◽  
Vol 30 (04) ◽  
pp. 458-470 ◽  
Author(s):  
Emmanuel Weitzenblum ◽  
Ari Chaouat ◽  
Matthieu Canuet ◽  
Romain Kessler
2015 ◽  
Vol 10s4 ◽  
pp. BMI.S29514
Author(s):  
Gabriele Grunig ◽  
Aram Baghdassarian ◽  
Sung-Hyun Park ◽  
Serhiy Pylawka ◽  
Bertram Bleck ◽  
...  

This review discusses biomarkers that are being researched for their usefulness to phenotype chronic inflammatory lung diseases that cause remodeling of the lung's architecture. The review focuses on asthma, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. Biomarkers of environmental exposure and specific classes of biomarkers (noncoding RNA, metabolism, vitamin, coagulation, and microbiome related) are also discussed. Examples of biomarkers that are in clinical use, biomarkers that are under development, and biomarkers that are still in the research phase are discussed. We chose to present examples of the research in biomarker development by diseases, because asthma, COPD, and pulmonary hypertension are distinct entities, although they clearly share processes of inflammation and remodeling.


Respiration ◽  
1985 ◽  
Vol 47 (3) ◽  
pp. 164-170 ◽  
Author(s):  
Marco Soroldoni ◽  
Fulvia Ferrarini ◽  
Enrico Biffi ◽  
Marzio Pozzi ◽  
Roberto Gatto ◽  
...  

2014 ◽  
Vol 11 (Supplement 3) ◽  
pp. S154-S160 ◽  
Author(s):  
M. Bradley Drummond ◽  
A. Sonia Buist ◽  
James D. Crapo ◽  
Robert A. Wise ◽  
Stephen I. Rennard

Sign in / Sign up

Export Citation Format

Share Document